Sana is Incorporating its Fusogen Technology to Develop SG293, a CD8-targeted Fusosome that Makes CD19-directed CAR T Cells in vivo; Expects to File IND for SG293 in B-cell Cancers and/or B-cell ...

According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...

India continues to face an alarming rise in air- and water-borne diseases, driven by rapid urbanization, population growth, ...

LUND, SE / ACCESS Newswire / December 9, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX)(STO:ATORX) today comments on ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...

Abxience, a Fresenius entity, and HP Inc., a global leader in technology, announce a new project to develop an innovative ...

INmune Bio Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune dysfunction to fight disease. The Company’s ...

Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off The latest announcement is out from Cellectis SA ( (CLLS)). On ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Aging is being reframed as a biological process that can be measured and potentially altered. The longevity market is ...

The biochips market is poised for robust growth driven by technological advancements and increased healthcare needs.

Today, the National Center for Advancing Translational Science (NCATS) at the National Institutes of Health (NIH) announced ...